← Lobby register
Disclosed budget
€10,000
Meetings 12mo
0
Policy files
0
Accredited passes
0
Recent meetings
| Date | Commissioner / Cabinet | Topic | File |
|---|---|---|---|
| 07 Feb 2025 | Wolfgang Philipp Principal Adviser | Discussion on availability and access to threat-specific monoclonal antibodies. | — |
| 07 Feb 2025 | Wolfgang Philipp Principal Adviser | Discussion on availability and access to threat-specific monoclonal antibodies. | SRC |
Mission & Goals
Develop monoclonal antibody drugs for neglected infectious diseases of importance in public health and biodefense.
EU Legislative Interests
Development of drugs for neglected diseases.
Communication Activities
None.
Interests Represented
Promotes their own interests or the collective interests of their members
Member Of
Not applicable.
Organisation Members
Employees of Mapp wish to have interactions with HERA.